Measurement of tear film thickness using ultrahigh-resolution optical coherence tomography

Invest Ophthalmol Vis Sci. 2013 Aug 15;54(8):5578-83. doi: 10.1167/iovs.13-11920.

Abstract

Purpose: To visualize the precorneal tear film with ultrahigh-resolution spectral domain optical coherence tomography, enabling quantification of tear film thickness in healthy subjects.

Methods: A custom-built spectral domain optical coherence tomography system comprising a broadband titanium:sapphire laser operating at 800 nm and a high-speed charge coupled device (CCD) camera with a read-out rate of 47 kHz was used for measurement of precorneal tear film thickness. The system provides a theoretical axial resolution of 1.2 μm in tissue. The signal-to-noise ratio close to the zero delay was measured with 94 dB. A total of 26 healthy subjects were included in this study. Measurement was started immediately after blinking and averaged over a period of 1 second. In a subset of eight healthy subjects, the reproducibility of the approach was studied by measuring the tear film thickness every 10 minutes over 1 hour.

Results: The average central tear film thickness of the measured population was 4.79 ± 0.88 μm. Reproducibility was very high, with an intraclass correlation coefficient of 0.97. A breakup of the tear film was observed in one subject after 14 seconds.

Conclusions: Our data indicate that the human precorneal tear film can be measured with excellent reproducibility using ultrahigh-resolution optical coherence tomography. This technique may be a valuable tool in the management of dry eye syndrome.

Trial registration: ClinicalTrials.gov NCT01746602.

Keywords: dry eyes; optical coherence tomography; tear film thickness.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blinking
  • Cornea / metabolism*
  • Cornea / pathology
  • Dry Eye Syndromes / diagnosis
  • Dry Eye Syndromes / metabolism
  • Dry Eye Syndromes / physiopathology
  • Female
  • Humans
  • Image Enhancement*
  • Male
  • Reference Values
  • Reproducibility of Results
  • Tears / chemistry*
  • Tomography, Optical Coherence / methods*
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT01746602